Activity of chymotrypsin-like proteinases in patients with ischemic heart disease, arterial hypertension and nonspecific aortic arteritis

Terapevticheskii Arkhiv

Volumn 72, Issue 11, 2000, Pages 37-39

  Arabidze, G G ^a   Belova, L A ^a   Chikhladze, N M ^a   Shapkina, L S ^a   Ogloblina, O G ^a   Kukharchuk, V V ^a  

^a NONE

Author keywords

Arterial hypertension; Cathepsin G; Chymase; Chymotrypsin like proteinases; Coronary heart disease; Nonspecific aortic arteritis

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN; CATHEPSIN G; CHYMASE; SERINE PROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; TEMPORAL ARTERITIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CATHEPSINS; CHYMASES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SERINE ENDOPEPTIDASES; SEVERITY OF ILLNESS INDEX; TEMPORAL ARTERITIS;

EID: 0034573129     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Böyum A. A one-stage procedurre for isolaton of granulocytes and lymphocytes from human blood. Scand. J. Clin. Lab. Invest. 1968; 21 (suppl.97): 51-76.
2. Metcalf Y. A., Gallin J. f., Nauseef W. M., Root R. K. Laboratory manual of neutrophil function. New York: Raven Press; 1986.
3. Kang S.-H., Fuchs M. S. An improvement in the Hummel chymotrypsin assay. Analit. Biochem. 1973; 54 (1): 262-265.
4. Liao Y., Husain A. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases. Can. J. Cardiol.. 1995; 11 (suppl. F): 13F-19F.
5. Takai S., Shiota N., Sakaguchi M. et al. Characterization of chymase from human vascular tissues. Clin. Acta 1997; 265: 13-20.
6. Urata H., Boehm K. D., Philip A. et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J. Clin. Invest. 1993; 91: 1269-1281.
7. Urata H., Kinoshita A., Misono K. S. et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 1990; 265 (1): 22348-22357.
8. Urata H., Strobel F., Ganten D. Widespread tissue distribution of human chymase. J. Hypertens. 1994; 12 (suppl.): S17-S22.
9. Wolny A., Closel J.-P., Rein J. et al. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ.Res. 1997; 80: 219-227.
10. Daemen M. J., Urata H. Healing human myocardial infarction associated with increased chymase immunoreactivity. Heart Vessels. 1997; suppl. 12: 113-115.
11. Marone G., Casolaro V., Patella V. et al. Molecular and cellular biology of mast cells and basophils. Int. Arch. Allegry Immunol. 1997; 114:207-217.
12. Okunishi H., Miyazpki At., Okamura T., Toda N. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem. Biophys. Res. Commun. 1987; 149: 1186-1192.
13. Okunishi H., Miyazaki M., Toda N. J. Hypertens. 1984; 2: 277-284.
14. Roks A., Buikema H., Pinto Y. M., van Gilst W. H. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I. Heart Vessels 1997; suppl. 12: 119-124.
15. Dell'Italia L. J., Balcells E., Meng Q. C. ct al. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am. J. Physiol. 1997; 273: H961-H970.
16. Kovanen P. Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease. Heart Vessels 1997; suppl. 12: 125-127.